Biocon Ltd.’s consolidated web revenue fell 84.3% within the second quarter of fiscal 2025, lacking analysts’ estimates.
The drugmaker’s revenue declined to Rs 27.1 crore within the September quarter, as in comparison with Rs 172.7 crore within the year-ago interval, in response to an trade submitting on Wednesday. That compares with the Rs 24-crore consensus estimate of analysts tracked by Bloomberg.
By David Morgan WASHINGTON (Reuters) - Prime nationwide safety advisers to President-elect Donald Trump and outgoing President Joe Biden are...
JPMorgan CEO Jamie Dimon is shaking off doomsday predictions about what AI means for humanity—as a substitute laying out how...
(Makes clear no remark from Thyssenkrupp (ETR:) Metal, not Thyssenkrupp in paragraph 3) BERLIN (Reuters) -Impartial specialists trying into the...
This text was written byComply withAfter 15 years working within the monetary sector, performing evaluation and judging danger administration at...
Maharashtra & Jharkhand Election Outcomes Winners Full Listing: On November 23, the Bharatiya Janata Social gathering-headed Mahayuti alliance received the race...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
